Ticker > Company >

Manipal Health Enter share price

Manipal Health Enterprises Ltd.

  10.91 K   3   2 NSE: MANIPALHOS BSE: 544847 SECTOR: Hospital & Healthcare Services

630.90
-11.50 (-1.79%)
NSE: Today, 03:09 PM

Price Summary

Today's High

₹ 644.65

Today's Low

₹ 625.2

52 Week High

₹ 815

52 Week Low

₹ 625.45

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 82987.15 Cr.

Enterprise Value

₹ 84959.67 Cr.

No. of Shares

131.54 Cr.

P/E

193.01

P/B

5.4

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  116.9

CASH

₹ 101.7 Cr.

DEBT

₹ 2074.22 Cr.

Promoter Holding

72.08 %

EPS (TTM)

₹  3.27

Sales Growth

15.46%

ROE

6.91 %

ROCE

9.33%

Profit Growth

-19.68 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year15.46%
3 Year14.17%
5 Year20.57%

Profit Growth

1 Year-19.68%
3 Year30.3%
5 Year95.05%

ROE%

1 Year6.91%
3 Year9.33%
5 Year8.93%

ROCE %

1 Year9.33%
3 Year12%
5 Year12.12%

Debt/Equity

0.2857

Price to Cash Flow

87.07

Interest Cover Ratio

3.7722

CFO/PAT (5 Yr. Avg.)

1.82566247464042

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Aug 2026 72.08 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 30.30427138968% for the Past 3 years.
  • The Company has been maintaining an effective average operating margins of 26.24108% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -219.0629 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.82566247464042.
  • The company has a high promoter holding of 72.08%.

 Limitations

  • The company has shown a poor revenue growth of 14.1730911292951% for the Past 3 years.
  • The company is trading at a high EV/EBITDA of 85.139.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2026
Net Sales 1048.3
Total Expenditure 798.25
Operating Profit 250.05
Other Income 40.87
Interest 61.59
Depreciation 64.14
Exceptional Items -13.43
Profit Before Tax 151.76
Tax 36.23
Profit After Tax 115.53
Adjusted EPS (Rs) 0.98

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 2119.56 2408.19 2706.95 3104.1 3584.13
Total Expenditure 1648.27 1735.55 1925.81 2258.63 2690.08
Operating Profit 471.29 672.64 781.14 845.47 894.05
Other Income 116.93 65.11 94.49 101.19 117.44
Interest 185.4 171.65 168.41 149.02 203.37
Depreciation 125.45 139.35 139.13 148.99 222.7
Exceptional Items 58.65 -141.88 -63.2 0 -21.64
Profit Before Tax 336.02 284.87 504.89 648.65 563.78
Tax 72.3 90.53 168.53 113.35 133.81
Net Profit 263.72 194.34 336.36 535.3 429.97
Adjusted EPS (Rs.) 2.32 1.71 2.97 23.16 3.64

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 75.63 75.63 75.63 77.06 235.95
Total Reserves 3099.62 3299.61 3822.21 5137.51 7087.52
Borrowings 870.37 1144.12 1160.65 1671.54 1920.99
Other N/C liabilities 418.17 396.78 436.53 744.26 1208.29
Current liabilities 1274.46 712.86 720.32 738.99 1138.1
Total Liabilities 5738.25 5629 6215.34 8369.36 11590.85
Assets
Net Block 1541.44 1543.7 1588.91 2375.37 5243.44
Capital WIP 20.87 26.91 19.73 582.75 561.24
Intangible WIP 367.6 347.2 357.78 0 0
Investments 2625.51 2569.96 2545.42 3563.51 3568.67
Loans & Advances 448.39 219.59 368.68 319.22 133.01
Other N/C Assets 117.39 14.82 29.58 33.91 8.15
Current Assets 617.05 906.82 1305.24 1494.6 2076.34
Total Assets 5738.25 5629 6215.34 8369.36 11590.85
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 336.02 284.87 504.89 648.65 563.78
Adjustment 196.67 394.02 298.83 242.29 365.48
Changes in Assets & Liabilities -103.15 63.71 -26.03 -91.89 136.87
Tax Paid -54.05 -126.6 -154 -154.77 -112.99
Operating Cash Flow 375.49 616 623.69 644.28 953.14
Investing Cash Flow -1465.32 -511.21 -405 -1851.58 -1002.75
Financing Cash Flow 1094.8 -96.65 -19.37 1107.19 23.49
Net Cash Flow 4.97 8.14 199.32 -100.11 -26.12

Corporate Actions

Investors Details

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q1FY27
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q1FY27

Company News

Manipal Health Enter Stock Price Analysis and Quick Research Report. Is Manipal Health Enter an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Manipal Health Enter. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Manipal Health Enter has a PE ratio of 196.52471855115 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Manipal Health Enter has ROA of 4.3083% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Manipal Health Enter has a Current ratio of 1.8244.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Manipal Health Enter has a ROE of 6.9125%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Manipal Health Enter has a Debt to Equity ratio of 0.2857 which means that the company has low proportion of debt in its capital.

  • Sales growth: Manipal Health Enter has reported revenue growth of 15.4644% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Manipal Health Enter for the current financial year is 24.9446867161626%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Manipal Health Enter is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Manipal Health Enter is Rs 3.2688. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Manipal Health Enter in Ticker for free. Also, one can get the intrinsic value of Manipal Health Enter by using Valuation Calculators, which are available with a Finology ONE subscription. 

Manipal Health Enter FAQs

Q1. What is Manipal Health Enter share price today?
Ans: The current share price of Manipal Health Enter is Rs 642.4.

Q2. What is the market capitalisation of Manipal Health Enter?
Ans: Manipal Health Enter has a market capitalisation of Rs 84499.83145648 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Manipal Health Enter?
Ans: The PE ratio of Manipal Health Enter is 196.52471855115 and the P/B ratio of Manipal Health Enter is 5.49527161988187, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Manipal Health Enter share?
Ans: The 52-week high share price of Manipal Health Enter is Rs 815, and the 52-week low share price of Manipal Health Enter is Rs 625.45.

Q5. Does Manipal Health Enter pay dividends?
Ans: Currently, Manipal Health Enter does not pay dividends. Dividend yield of Manipal Health Enter is around 0%.

Q6. What are the face value and book value of Manipal Health Enter shares?
Ans: The face value of Manipal Health Enter shares is Rs 2, while the book value per share of Manipal Health Enter is around Rs 116.9005. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Manipal Health Enter?
Ans: Manipal Health Enter has a total debt of Rs 2074.22 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Manipal Health Enter?
Ans: The ROE of Manipal Health Enter is 6.9125% and ROCE of Manipal Health Enter is 9.3332%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Manipal Health Enter a good buy for the long term?
Ans: The Manipal Health Enter long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Manipal Health Enter undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Manipal Health Enter appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Manipal Health Enter’s financials?
Ans: You can review Manipal Health Enter’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Manipal Health Enter
X